molecular diagnostics News
Most Popular molecular diagnostics Story
Qiagen acquires Genaco in $40M deal
Qiagen has acquired Huntsville, AL-based Genaco Biomedical Products for $22 million in cash plus shares. The deal also includes up to $18 million in milestone payments. The deal gives Qiagen ownership of Genaco's expertise in multiplexing technology for diagnostics work. In multiplexing, a diagnostic test screens for more than 10 targets when patients present symptoms that could be attributed to a variety of causes. Multiplexing, for example, could be used to test for hospital acquired …
... Read more...Latest Headlines
- October 16, 2008
- June 3, 2008
- March 20, 2008
- March 17, 2008
- January 8, 2008
- January 4, 2008
- August 28, 2007
- January 17, 2007
- January 2, 2007
- October 29, 2006
- May 31, 2006
- May 15, 2006
- May 3, 2006
- March 15, 2006
- January 11, 2006
- January 8, 2006
- September 28, 2005
- August 3, 2005
- June 20, 2005
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
